Correction to: HLA Class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

• by Jie Mei, Guanyu Jiang, Yundi Chen, Yongrui Xu, Yuan Wan, Ruo Chen, Feng Liu, Wenjun Mao, Mingfeng Zheng, Junying Xu

• September 17, 2026

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

• by

• September 4, 2026

• 4 min

Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα

• by Fei Lv, XiaoQi Li, Ying Wang

• September 11, 2026

Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening

• by Pianpian Cao, Laney Smith, Emma Tian, Lou-Anne Chichester, Elizabeth Schofield, Randi M. Williams, Rafael Meza, Benjamin A. Toll, Jamie Ostroff, Elena B. Elkin, Steven S. Fu, Stephanie R. Land, Kathryn L. Taylor, Jinani Jayasekera

• September 14, 2026